# EDGAR Filing Document

**Accession Number:** 0001657573
**File Stem:** 0001562180-23-002933
**Filing Date:** 2023-3
**Character Count:** 9747
**Document Hash:** 2bcae41677b4a314d917869cc981245c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-002933.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0001562180-23-002933

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230315

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230317

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Leibel Matthew
- **CENTRAL INDEX KEY:** 0001944062

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40546
- **FILM NUMBER:** 23744694

**MAIL ADDRESS:**
- **STREET 1:** 7529 STANDISH PLACE, SUITE 200
- **STREET 2:** CO XOMETRY, INC.
- **CITY:** DERWOOD
- **STATE:** MD
- **ZIP:** 20855
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xometry, Inc.
- **CENTRAL INDEX KEY:** 0001657573
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **IRS NUMBER:** 320415449
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 6116 EXECUTIVE BOULEVARD, SUITE 800
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852
- **BUSINESS PHONE:** 240-335-7914

**MAIL ADDRESS:**
- **STREET 1:** 6116 EXECUTIVE BOULEVARD, SUITE 800
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852

## Ex-24

```

POWER OF ATTORNEY
(For Executing Form ID and Forms 3, 4 and 5)

Know all by these presents, that the undersigned hereby constitutes and
appoints each of Eric Blanchard, Trey Reilly and Nicholas Balenger of Cooley
LLP, and Kristie Scott and James Rallo of Xometry, Inc. (the "Company"),
signing individually, the undersigned's true and lawful attorneys-in-fact and
agents to:

(1) Prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the Securities and Exchange Commission (the "SEC"), a
Form ID and Forms 3, 4 and 5 (including amendments thereto and joint filing
agreements in connection therewith) in accordance with Section 16 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the
rules thereunder, in the undersigned's capacity as an officer, director or
beneficial owner of more than 10% of a registered class of securities of the
Company;

(2) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare and execute any such Form ID and
Forms 3, 4 or 5 (including amendments thereto and joint filing agreements in
connection therewith) and file such forms with the SEC and any stock
exchange, self-regulatory association or any similar authority; and

(3) Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required of the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as the attorney-in-fact may approve
in the attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney in fact, or such attorney in fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, and their substitutes, in serving in such
capacity at the request of the undersigned, are not assuming (nor is the
Company assuming) any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file
Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, (b) revocation by the
undersigned in a signed writing delivered to the Company and the foregoing
attorneys-in fact or (c) as to any attorney-in-fact individually, until such
attorney-in-fact is no longer employed by the Company or employed by or a
partner at Cooley LLP or another law firm representing the Company, as
applicable.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of August 17, 2022.

By:  /s/ Matthew Leibel
Signature - Matthew Leibel
Matthew Leibel

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Leibel Matthew<br><sub>(Last) (First) (Middle)</sub><br>C/O XOMETRY, INC.<br>6116 EXECUTIVE BLVD, SUITE 800<br><sub>(Street)</sub><br>NORTH BETHESDA, MD 20852<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Technology Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Xometry, Inc. [ XMTR ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2023-03-15 |  | A |  | 39430.00<sup>(1)</sup> | A | 0.00<sup>(2)</sup> | 73163.00 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to buy) | $15.82 | 2023-03-15 |  | A |  | 58813.00 |  | <sup>(3)</sup> | 2033-03-14 | Class A Common Stock | 58813.00 | $0.00 | 58813.00 | D |  |

---

### Footnotes:

(1) Represents a restricted stock unit ("RSU") grant. One quarter (1/4) of the shares underlying the RSUs will vest on January 1, 2024 and the remainder of the shares underlying the RSUs vest quarterly for the 3 years thereafter, subject to the Reporting Person's continuous service.

(2) Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer.

(3) One quarter (1/4) of the options will vest on January 1, 2024, and the remainder of the options vest quarterly for the 3 years thereafter, subject to the Reporting Person's continuous service.

**Signature:** /s/ Kristie Scott, Attorney-in-Fact  
**Date:** 2023-03-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**